JPRN-UMIN000014927已完成1 期
Phase I trial of definitive chemoradiotherapy with paclitaxel, cisplatin, and 5-FU (PCF-RT) for esophageal cancer - Phase I trial of definitive chemoradiotherapy with paclitaxel, cisplatin, and 5-FU (PCF-RT) for esophageal cancer
Aichi Cancer Center Hospital0 个研究点目标入组 18 人开始时间: 2014年8月22日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Histologically proven squamous cell carcinoma or adenocarcinoma or adenosquamous cell carcinoma or basal cell carcinoma of the esophagus 2) Primary lesion are located within the thoracic esophagus (Te) 3) Clinical stage I or II or III or IV (with supraclavicular LN) 4) Total radiation dose is 50.4Gy 5) Aged 20 to 75 years old 6) ECOG PS of 0 or1 7) no need for measurable lesion 8) no previous treatment of esophageal cancer except EMR or ESD 9) no previous chemotherapy or radiotherapy against any other malignancies 10) adequate organ functions 11) refused esophagectomy 12) written informed consent
研究者
相似试验
已完成
1 期
Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Canceradvanced or recurrence esophageal carcinomaJPRN-UMIN000003634Department of Surgery, Graduate School of Medicine, Osaka University18
尚未招募
1 期
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
招募中
1 期
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24
已完成
不适用
A pilot study of definitive chemoradiotherapy using involved-field intensity-modulatd radiation therapy for patients with clinical stage IB-IIIC (non T4) esophageal carcinomaEsophageal neoplasmJPRN-UMIN000017668Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University12
已完成
2 期
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)locally advanced esophageal carcinomaJPRN-UMIN000002029Kitasato University School of Medicine35